Generation of a human induced pluripotent stem cell line from a patient diagnosed with schizophrenia carrying a 16p11.2 deletion

Generation of a human induced pluripotent stem cell line from a patient diagnosed with schizophrenia carrying a 16p11.2 deletion

16p11.2 copy number variations have been associated with neurodevelopmental disorders. Human induced pluripotent stem cells were generated from fibroblasts obtained from a patient diagnosed with schizophrenia with a 16p11.2 deletion. The generated cell line was further validated for its pluripotency...

Full description

Bibliographic Details
Main Authors:	Deniz A. Madencioglu, Karina Kruth, Mallory Shin, Nancy Andreasen, Thomas Wassink, Aislinn Williams
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506121004839

Similar Items

Identification of 22q11.2 deletion in a patient with schizophrenia and clinically diagnosed Rubinstein–Taybi syndrome
by: Yasuhito Nagai, et al.
Published: (2022-09-01)

Touch and olfaction/taste differentiate children carrying a 16p11.2 deletion from children with ASD
by: Joana Maria Almeida Osório, et al.
Published: (2021-02-01)

Neuronal deletion of CaV1.2 is associated with sex-specific behavioral phenotypes in mice
by: Annette J. Klomp, et al.
Published: (2022-12-01)

Phenotype variability in thirteen 16p11.2 deletion patients
by: Diana Rodà, et al.
Published: (2018-07-01)

SCN2A channelopathies in the autism spectrum of neuropsychiatric disorders: a role for pluripotent stem cells?
by: Karina A. Kruth, et al.
Published: (2020-04-01)

A highly penetrant form of childhood apraxia of speech due to deletion of 16p11.2
by: Fedorenko, Evelina, et al.
Published: (2018)

MicroRNA dysregulation, gene networks and risk for schizophrenia in 22q11.2 deletion syndrome
by: Daniele eMerico, et al.
Published: (2014-11-01)

Hypocalcemia due to 22q11.2 deletion syndrome diagnosed in adulthood
by: Maria Cabrer, et al.
Published: (2018-01-01)

Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13
by: Takeshi Niki, et al.
Published: (2019-01-01)

Treatment‐resistant schizophrenia with 22q11.2 deletion and additional genetic defects
by: Sawako Furukawa, et al.
Published: (2024-12-01)

miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome
by: Linda M Brzustowicz, et al.
Published: (2012-12-01)

Genomic deletions on 16p11.2 associated with severe obesity in Brazil
by: Izadora Sthephanie da Silva Assis, et al.
Published: (2025-01-01)

Abnormal auditory and language pathways in children with 16p11.2 deletion
by: Jeffrey I. Berman, et al.
Published: (2015-01-01)

Large 3‐Mb deletions at 22q11.2 locus in Parkinson's disease and schizophrenia
by: Foo, Jia Nee, et al.
Published: (2020)

An interictal schizophrenia-like psychosis in an adult patient with 22q11.2 deletion syndrome
by: Yasutaka Tastuzawa, et al.
Published: (2015-01-01)

A Case for Thalamic Mechanisms of Schizophrenia: Perspective From Modeling 22q11.2 Deletion Syndrome
by: Yanbo Jiang, et al.
Published: (2021-12-01)

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.
by: Walters, R, et al.
Published: (2010)

Hyperinsulinism in a patient with a Zellweger Spectrum Disorder and a 16p11.2 deletion syndrome
by: Eva M.M. Hoytema van Konijnenburg, et al.
Published: (2020-06-01)

Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder
by: Candace B. Borders, et al.
Published: (2017-10-01)

Chromosome 16p11.2 deletions: another piece in the genetic puzzle of childhood obesity
by: del Giudice Emanuele, et al.
Published: (2010-06-01)

Generation and characterization of induced pluripotent stem cell line (IBBISTi004-A) from an Angelman syndrome patient carrying a class II deletion of the maternal chromosome 15q11.2-q13
by: Carina Maranga, et al.
Published: (2022-05-01)

Prenatally diagnosed case of 22q11.2 deletion syndrome associated with pulmonary artery aneurysm
by: Leyla Ozer, et al.
Published: (2012-02-01)

Induced pluripotent stem cells derived from a schizophrenia patient with ASTN2 deletion
by: Yuko Arioka, et al.
Published: (2018-07-01)

Generation of human induced pluripotent stem cell lines carrying homozygous JAG1 deletions
by: Dan Song, et al.
Published: (2021-12-01)

A case study of the utilization of clozapine treatment for treatment‐resistant schizophrenia associated with 22q11.2 deletion syndrome
by: Arisa Tsurue, et al.
Published: (2023-06-01)

Pervasive alterations of intra-axonal volume and network organization in young children with a 16p11.2 deletion
by: Anne M. Maillard, et al.
Published: (2024-02-01)

Behavioral Abnormalities and Circuit Defects in the Basal Ganglia of a Mouse Model of 16p11.2 Deletion Syndrome
by: Thomas Portmann, et al.
Published: (2014-05-01)

Incidence of infective endocarditis in adults with congenital heart disease and diagnosed 22q11.2 deletion syndrome
by: Adonis Ng, et al.
Published: (2021-10-01)

Experiences and concerns of parents of children with a 16p11.2 deletion or duplication diagnosis: a reflexive thematic analysis
by: Charlotte E. Butter, et al.
Published: (2024-03-01)

Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult
by: Melissa Elise van der Meijs, et al.
Published: (2021-04-01)

Reduced fronto-temporal and limbic connectivity in the 22q11.2 deletion syndrome: vulnerability markers for developing schizophrenia?
by: Marie-Christine Ottet, et al.
Published: (2013-01-01)

Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes.
by: Thomas Arbogast, et al.
Published: (2016-02-01)

MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review
by: Andreas J. eForstner, et al.
Published: (2013-12-01)

Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes
by: Roberta Leone, et al.
Published: (2024-06-01)

Day-to-day spontaneous social behaviours is quantitatively and qualitatively affected in a 16p11.2 deletion mouse model
by: Anna Rusu, et al.
Published: (2023-12-01)

Schizophrenia patients and 22q11.2 deletion syndrome adolescents at risk express the same deviant patterns of resting state EEG microstates: A candidate endophenotype of schizophrenia
by: Miralena I. Tomescu, et al.
Published: (2015-09-01)

Deletion Syndrome 22q11.2: A Systematic Review
by: Jonathan Cortés-Martín, et al.
Published: (2022-08-01)

Circuit mechanism underlying fragmented sleep and memory deficits in 16p11.2 deletion mouse model of autism
by: Ashley Choi, et al.
Published: (2024-12-01)

Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder.
by: Daniela Brunner, et al.
Published: (2015-01-01)

Structural and Lipidomic Alterations of Striatal Myelin in 16p11.2 Deletion Mouse Model of Autism Spectrum Disorder
by: Jun Ju, et al.
Published: (2021-08-01)